Clinical Trial Update: Circulating miRNA in Primary Hyperparathyroidism

View source ↗

Summary

A completed University of Pennsylvania clinical trial investigates circulating microRNAs as biomarkers in primary hyperparathyroidism, with related consideratio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism
• Osteoporosis
• Postmenopausal Osteoporosis

Snippet

Sponsor: University of Pennsylvania | Conditions: Primary Hyperparathyroidism, Osteoporosis, Postmenopausal | Status: COMPLETED